Physician

Kayode C. Lawrence, M.D.

According to 2025 Medicare claims, Kayode Lawrence, M.D. (NPI: 1689617177) practices nephrology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1821159021; TIN: 23-2730785) and primary practice location at 17325-7878. Lawrence is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Lawrence's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 540 traditional Medicare patients, billed 1,567 HCPCS/CPT codes, and received $155,555 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,905 prescription claims across 434 beneficiaries totaling $404,256 in drug costs, led by Jardiance (Empagliflozin). DME data shows 111 claims. Open Payments data shows 4 records totaling $162. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $73,377 to $404,256. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$102K$204K2015 Medicare payment: $179,250 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $170,508 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $176,654 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $186,404 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $204,154 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $191,312 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $201,913 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $194,632 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $182,805 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $155,555 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155701,780$179,250
20165331,540$170,508
20175291,645$176,654
20185531,773$186,404
20196071,981$204,154
20205971,795$191,312
20216221,772$201,913
20226191,885$194,632
20235541,694$182,805
20245401,567$155,555

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$202K$404K2015 Drug cost: $73,377 (USD; Tot_Drug_Cst)2016 Drug cost: $92,428 (USD; Tot_Drug_Cst)2017 Drug cost: $160,922 (USD; Tot_Drug_Cst)2018 Drug cost: $138,597 (USD; Tot_Drug_Cst)2019 Drug cost: $139,752 (USD; Tot_Drug_Cst)2020 Drug cost: $127,571 (USD; Tot_Drug_Cst)2021 Drug cost: $194,555 (USD; Tot_Drug_Cst)2022 Drug cost: $180,345 (USD; Tot_Drug_Cst)2023 Drug cost: $260,244 (USD; Tot_Drug_Cst)2024 Drug cost: $404,256 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152221,584$73,377
20162121,662$92,428
20172411,876$160,922
20182371,881$138,597
20192922,409$139,752
20202912,477$127,571
20213522,424$194,555
20223732,509$180,345
20234162,758$260,244
20244342,905$404,256

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.7K$11K2015 Medicare payment: $11,322 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,027 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,385 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,964 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,734 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $153 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,936 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,145 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $516 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,966 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R154$11,322
2016N/R84$4,027
2017N/R69$2,385
2018N/R102$2,964
2019N/R69$1,734
2020N/R12$153
2021N/R48$1,936
2022N/R48$1,145
2023N/R27$516
2024N/R111$1,966

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more3838$102
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes7381$98
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4597$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more343572$87
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes111238$59

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin1004,536$83,985
FarxigaDapagliflozin Propanediol723,720$65,805
XphozahTenapanor Hcl18660$61,994
LokelmaSodium Zirconium Cyclosilicate382,406$43,686
VeltassaPatiromer Calcium Sorbitex18956$27,104

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7507Tacrolimus, immediate release, oral, 1 mgNN/R22$681
J7517Mycophenolate mofetil, oral, 250 mgNN/R22$467
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R34$414
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R21$395
J7512Prednisone, immediate release or delayed release, oral, 1 mgNN/R12$9

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$162CALLIDITAS THERAPEUTICS US INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kayode C. Lawrence, M.D.?

Tedicare shows public-source Medicare data for Kayode C. Lawrence, M.D. (NPI 1689617177), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kayode C. Lawrence, M.D. have ACO affiliation data?

Kayode C. Lawrence, M.D. is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Kayode C. Lawrence, M.D.?

Kayode C. Lawrence, M.D. is linked to WELLSPAN MEDICAL GROUP (billing NPI 1821159021) in the available physician profile data.

Does Kayode C. Lawrence, M.D. have Open Payments data?

Kayode C. Lawrence, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.